Search
for
Sort by
Research 721–750 of 777
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Hidradenitis Suppurativa Tunnels: Unveiling a Unique Disease Entity
- CXCL12+ dermal fibroblasts promote neutrophil recruitment and host defense by recognition of IL-17
- Transcription factor-based transdifferentiation of human embryonic to trophoblast stem cells
- Atopic diseases and the risk of alopecia areata among pre-teens and teenagers in Taiwan
- 1,314
- European expert consensus statement on the systemic treatment of alopecia areata
- UHPLC-Q-Orbitrap HRMS-based Metabolomics and In Silico Studies on 5-α-Reductase, JAK1, JAK2, and JAK3 of <i>Albizia saponaria</i> L.: Application to Alopecia
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)
- An updated review of the sebaceous gland and its role in health and diseases Part 2: Pathophysiological clinical disorders of sebaceous glands
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- 056 IL-15 prolongs hair growth and operates as a guardian of human hair follicle immune privilege
- 705 Particulate matter induces inflammatory response in human outer root sheath cells via oxidative stress-dependent MAPK and JAK-STAT signaling pathways
- Alopecia areata – Current understanding and management
- Alopecia areata – Aktuelles Verständnis und Management
- Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: e-Posters
- NUMERICAL DESCRIPTOR COMPUTATION OF ALOPECIA DRUGS USING COM – POLYNOMIAL
- Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models
- O PROCESSO DE ENFERMAGEM NO TRANSPLANTE CAPILAR: O IMPACTO DOS CUIDADOS PERIOPERATÓRIOS
- TNC+ fibroblasts involve in skin inflammation via neuro-immune and interacting with T cells
- Mendelian Randomization Identifies CD25+ CD4+ Tregs and Plasma Proteins in Androgenetic Alopecia Pathogenesis
- Interleukin-15 is a hair follicle immune privilege guardian
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- 41701 Efficacy of the Oral JAK1/JAK2 Inhibitor CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata: Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 Phase 3 Trial
- CS12192 Reverses Alopecia Areata by Selectively Targeting JAK3/JAK1/TBK1.
- Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata
- Treatment of moderate-to-severe alopecia areata in pre-adolescent children with baricitinib
- Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
- Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata